MessagesRepliesFor YouTutorial
MessagesRepliesFor YouTutorial
This reply
Jesse Lin mark this message contains true information
｜originally written by Jesse Lin

針對
分析38萬的人口,
AZ vs BNT
第一劑 61% vs 66%,
第二劑79% vs 80%,
這些資料上文章都有提及

Using 1,945,071 real-time PCR results from nose and throat swabs taken from 383,812 participants between 1 December 2020 and 8 May 2021, we found that vaccination with the ChAdOx1 or BNT162b2 vaccines already reduced SARS-CoV-2 infections ≥21 d after the first dose (61% (95% confidence interval (CI) = 54–68%) versus 66% (95% CI = 60–71%), respectively), with greater reductions observed after a second dose (79% (95% CI = 65–88%) versus 80% (95% CI = 73–85%), respectively).

References

https://www.nature.com/articles/s41591-021-01410-w

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

Results from the Office of National Statistics COVID-19 Infection Survey in the United Kingdom demonstrate that the ChAdOx1 nCoV-19 and BNT162b2 vaccines reduce the incidence of new SARS-CoV-2 infecti

https://www.nature.com/articles/s41591-021-01410-w
The reply is used in the following messages
AZ vs 輝瑞-大規模實證論文出來了,發表在2021/6/9 Nature Medicine.
分析38萬的人口,
AZ vs BNT
第一劑 61% vs 66%,
第二劑79% vs 80%,
結論：
一樣有效， 以PCR的Ct值判斷感染，兩種疫苗保護力很接近,幾乎一模一樣，對於Ct值<30以及有症狀的保護力尤其明顯

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.